IN2014DN07174A - - Google Patents

Info

Publication number
IN2014DN07174A
IN2014DN07174A IN7174DEN2014A IN2014DN07174A IN 2014DN07174 A IN2014DN07174 A IN 2014DN07174A IN 7174DEN2014 A IN7174DEN2014 A IN 7174DEN2014A IN 2014DN07174 A IN2014DN07174 A IN 2014DN07174A
Authority
IN
India
Prior art keywords
cosmetic
present
skin
ion introduction
wrinkling
Prior art date
Application number
Other languages
English (en)
Inventor
Minoru Ueda
Yasuhiro Yamashita
Original Assignee
Japanic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanic Corp filed Critical Japanic Corp
Publication of IN2014DN07174A publication Critical patent/IN2014DN07174A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/328—Applying electric currents by contact electrodes alternating or intermittent currents for improving the appearance of the skin, e.g. facial toning or wrinkle treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
IN7174DEN2014 2012-02-10 2013-02-08 IN2014DN07174A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012027852 2012-02-10
PCT/JP2013/053094 WO2013118877A1 (ja) 2012-02-10 2013-02-08 非ヒト幹細胞の培養上清を原材料とする化粧品又は皮膚再生促進剤、及びタンパク質のイオン導入方法

Publications (1)

Publication Number Publication Date
IN2014DN07174A true IN2014DN07174A (zh) 2015-04-24

Family

ID=48947632

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7174DEN2014 IN2014DN07174A (zh) 2012-02-10 2013-02-08

Country Status (10)

Country Link
US (1) US20150018750A1 (zh)
EP (1) EP2813211A4 (zh)
JP (1) JP6286689B2 (zh)
KR (2) KR20180128097A (zh)
CN (2) CN107049910A (zh)
HK (1) HK1204568A1 (zh)
IN (1) IN2014DN07174A (zh)
SG (1) SG11201404603SA (zh)
TW (1) TWI649095B (zh)
WO (1) WO2013118877A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2848285A1 (en) * 2013-09-13 2015-03-18 Blue Horizon International LLC Compositions comprising medium supernatant of a stem cell culture
FR3015050B1 (fr) * 2013-12-18 2017-02-17 Inst De Radioprotection Et De Surete Nucleaire Espece radicalaire et procede pour la mesure de doses recues
CN118161529A (zh) * 2014-11-07 2024-06-11 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
JP2016128396A (ja) * 2015-01-09 2016-07-14 上田　実 ｉＰＳ細胞培養上清を含む医薬組成物およびその製造方法、化粧品およびその製造方法、抗加齢組成物、疾患発症抑制方法、疾患治療方法、組織異常治療方法ならびに美容方法
JP2016150919A (ja) * 2015-02-18 2016-08-22 ピアス株式会社 塗布用化粧品組成物
US10870830B2 (en) 2015-03-26 2020-12-22 EWHA University—Industry Collaboration Foundation Method for culturing differentiation-promoting and -sustaining spheroid form of tonsil-derived stem cells
JP6505210B2 (ja) 2015-04-27 2019-04-24 株式会社Ｑｕａｒｒｙｍｅｎ＆Ｃｏ． シート状小片、その小片を含む発毛促進用シート、並びに、その小片を含む美白及び皺改善剤
JP6868565B2 (ja) * 2015-11-05 2021-05-12 株式会社Ｃｙｓａｙ 不死化幹細胞、及びその作製方法
US10224149B2 (en) * 2015-12-09 2019-03-05 Kemet Electronics Corporation Bulk MLCC capacitor module
JP2017118952A (ja) * 2015-12-28 2017-07-06 株式会社キレートジャパン フェイスマスク包装体
CN109414459B (zh) * 2016-03-24 2022-10-25 斯坦姆实验室 源自脐带血的外泌体用于组织修复的用途
JP6152205B1 (ja) * 2016-08-09 2017-06-21 仁幸 小林 化粧品、医薬用組成物、およびそれらの製造方法
EP3607957A4 (en) * 2017-05-02 2020-12-16 Koji Tanabe PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION
CN107823631A (zh) * 2017-11-17 2018-03-23 广州赛莱拉干细胞科技股份有限公司 一种组合物及其制备方法与在制备治疗糖尿病足溃疡的药物中的应用
CN108721602A (zh) * 2018-06-28 2018-11-02 天津市康婷生物工程有限公司 一种联合ha促进毛发再生的干细胞新型生发剂
CN109331172A (zh) * 2018-06-28 2019-02-15 天津市康婷生物工程有限公司 一种促进毛发再生的干细胞新型生发剂
US20210260135A1 (en) * 2018-08-03 2021-08-26 Laboratory Of Cell Applied Technologies, Co Production Method for Culture Supernatant Preparation
JP6884935B2 (ja) * 2018-12-20 2021-06-09 株式会社システムエッヂ 再生治療用組成物の製造方法
KR102155141B1 (ko) * 2019-01-02 2020-09-11 주식회사 티아라줄기세포연구소 줄기세포파쇄추출물(무막줄기세포) 및 커피원두분쇄가루를 이용한 아토피 피부용 스크럽워시
JP2020164473A (ja) * 2019-03-29 2020-10-08 株式会社再生医学研究所 歯髄幹細胞培養上清と毛乳頭幹細胞培養上清とを含む育毛剤およびその製造方法
JPWO2022244851A1 (zh) * 2021-05-19 2022-11-24

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2539291C2 (de) * 1975-09-04 1983-07-28 Henkel KGaA, 4000 Düsseldorf Zweikomponentenverpackung
US5262319A (en) * 1985-04-19 1993-11-16 Oncogene Science, Inc. Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
AU630106B2 (en) * 1988-07-15 1992-10-22 Trustees Of Columbia University In The City Of New York, The Tumor necrosis enhancing factor and methods of preparation and use
US5055447A (en) * 1988-07-28 1991-10-08 Genentech, Inc. Method and compositions for the treatment and prevention of septic shock
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
DE69133328T2 (de) * 1990-03-30 2004-07-29 Alza Corp., Palo Alto Vorrichtung zur iontophoretischen verabreichung
US6344321B1 (en) * 1990-06-11 2002-02-05 Gilead Sciences, Inc. Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
KR100449141B1 (ko) 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
JP2003019214A (ja) * 2001-07-06 2003-01-21 Sunsorit:Kk イオン導入機
JP2003038660A (ja) * 2001-07-26 2003-02-12 Masaru Takahashi 電導体付薬剤含侵シート
EP1661578B1 (en) * 2003-09-03 2018-03-14 Toshikazu Nakamura Skin ulcer preventive curative agent containing human recombinant hgf
FR2866240B1 (fr) * 2004-02-16 2006-06-23 Oreal Kit de traitement comportant une structure composite a appliquer sur la peau et un excitateur electrique
FR2870739B1 (fr) 2004-05-26 2008-05-16 Oreal Utilisation du lif en cosmetique et en dermatologie
JP2007015289A (ja) * 2005-07-08 2007-01-25 Noritsu Koki Co Ltd リボンカセット
KR100955212B1 (ko) * 2006-01-27 2010-04-29 (주)프로스테믹스 지방유래 줄기세포를 이용한 성장인자의 대량 생산방법
US20070185431A1 (en) * 2006-02-03 2007-08-09 Kern Dale G Galvanic Current Skin Treatment
US20090048193A1 (en) * 2006-05-26 2009-02-19 Rusconi Christopher P Administration of the REG1 anticoagulation system
US20100143439A1 (en) * 2007-04-16 2010-06-10 University Of Toledo Hybrid Biomimetic Particles, Methods of Making Same and Uses Therefor
US8283314B1 (en) * 2007-07-02 2012-10-09 Jan Marini Skin Research, Inc. Skin care compositions
WO2009037748A1 (ja) * 2007-09-19 2009-03-26 Drug Safety Testing Center Co., Ltd. 安全性薬理試験方法
KR100963930B1 (ko) * 2007-12-07 2010-06-17 주식회사 신한은행 스캐닝 데이터 보험 상품 운용 방법 및 시스템과 이를 위한 기록매체
JP2010006734A (ja) * 2008-06-26 2010-01-14 Pars Co Ltd 成長因子を含む皮膚外用剤及びバイオ製品とその保存方法
AU2009271598A1 (en) * 2008-07-15 2010-01-21 Briannan Bintz Wound healing
JP5793724B2 (ja) * 2008-08-22 2015-10-14 公益財団法人ヒューマンサイエンス振興財団 脳梗塞治療材
CN101461772A (zh) * 2009-01-07 2009-06-24 天津欧瑞生物科技有限公司 用于美容护肤的干细胞分泌因子的制备方法
WO2010093848A1 (en) * 2009-02-13 2010-08-19 Invitrx, Inc. Skin cream
US20130195991A1 (en) * 2010-03-26 2013-08-01 National University Corporation Nagoya University Composition for Treatment of Damaged Part
CN103635198A (zh) * 2010-11-12 2014-03-12 阿勒根公司 经代谢的经调节的生长培养基和使用方法

Also Published As

Publication number Publication date
CN107049910A (zh) 2017-08-18
TW201343195A (zh) 2013-11-01
EP2813211A1 (en) 2014-12-17
JPWO2013118877A1 (ja) 2015-05-11
KR20140130159A (ko) 2014-11-07
TWI649095B (zh) 2019-02-01
WO2013118877A1 (ja) 2013-08-15
HK1204568A1 (zh) 2015-11-27
JP6286689B2 (ja) 2018-03-14
KR20180128097A (ko) 2018-11-30
US20150018750A1 (en) 2015-01-15
CN104203211A (zh) 2014-12-10
SG11201404603SA (en) 2014-10-30
EP2813211A4 (en) 2015-11-04

Similar Documents

Publication Publication Date Title
IN2014DN07174A (zh)
PH12018501295A1 (en) Differentiation of human embryonic stem cells into pancreatic endocrine cells
HK1218927A1 (zh) 人類多能幹細胞在限定條件下進行血液內皮分化的方法和材料
EP2826855A4 (en) METHOD FOR PRODUCING MIXTURE OF CARDIAC AND VASCULAR CELLS FROM ARTIFICIAL PLURIPOTENT STEM CELLS
EP2794860A4 (en) METHOD OF INDUCING A DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS INTO INTERMEDIATE MESODERM CELLS
AU2013312359A8 (en) Genetically modified non-human animals and methods of use thereof
IL227919A0 (en) Methods and preparations for the production of stem cells related to highly active nerve cells specific to the patient
SG11201405875PA (en) Methods and compositions for regenerating and repairing damaged tissue using nonviable irradiated or lyophilized pluripotent stem cells
EP2897582A4 (en) METHOD AND COMPOSITIONS FOR ENHANCING SELECTIVE CATABOLISM IN CELLS OF KERATIN SURFACES
MX349544B (es) Extractos de maesa japonica y métodos de uso.
MY163257A (en) Humanised anti-cd52 antibodies
MX2015003701A (es) Composiciones para tratamiento.
EP3003290A4 (en) Compositions and methods for induced tissue regeneration in mammalian species
EP2904438A4 (en) CONTAINER AND METHOD FOR IN-LINE ANALYSIS OF PROTEIN COMPOSITIONS
NZ703345A (en) Compositions and methods for reducing frequency and/or severity of headache
IN2015DN00344A (zh)
IL229462A0 (en) Formulation and method for transferring and harvesting human stem cells that can develop in different directions
EP2845862A4 (en) PROCESS FOR INCUBATING PLURIPOTENTER STEM CELLS AND POLYPEPTIDES FOR THE USE THEREOF
EP2716300A4 (en) APPLICATION FOR PRDX2 AND / OR PRDX6 IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DAMAGE, AGING OR DISEASE RESULTING FROM THE INCREASE IN OXYGEN REACTIVE SPECIES
EP3064576A4 (en) POLYPEPTIDE COMPOSITION AND METHOD FOR CULTURING PLURIPOTENT STEM CELLS USING THE SAME
HK1256129A1 (zh) 用於刺激皮膚細胞中的膠原合成的方法和組合物
GB2534478A (en) Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10
EP2858581A4 (en) METHOD FOR IN VITRO DIFFERENTIATION OF MOTONEURONE PROGENITORS (MNPS) FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, AND CRYOPRESERVATION OF MNPS
WO2014005153A3 (en) Methods for treating mds1-evi1 mediated cancer
HK1213491A1 (zh) 含有人參果提取物的用於改善女性健康和生活質量的組合物